Thema
Journal Article
24
Multiple sclerosis
19
Letter
6
COVID-19
4
multiple sclerosis
4
Andrographolide
3
Autoantibodies
3
Brain atrophy
3
Comment
3
Disability progression
3
Epilepsy surgery
3
MRI
3
Multicenter Study
3
Multiple Sclerosis
3
NMOSD
3
Natalizumab
3
Progressive multiple sclerosis
3
Research Support, Non-U.S. Gov't
3
4F4X42SYQ6
2
Acetazolamide
2
Alemtuzumab
2
Anticonvulsants
2
Aquaporin 4
2
Biological drugs
2
Biosimilar
2
Cerebellum
2
Clonazepam
2
Editorial
2
Glatiramoids
2
Immunologic Factors
2
Interferon beta
2
Latin America
2
MOGAD
2
Myelin-Oligodendrocyte Glycoprotein
2
Observational Study
2
Ocrelizumab
2
Phenotype
2
Rituximab
2
Sclerosis
2
Thalamus
2
magnetic resonance imaging
2
0Z5B2CJX4D
1
410105JHGR
1
44YRR34555
1
570
1
5PE9FDE8GB
1
6158TKW0C5
1
Adverse drug reaction
1
Adverse events
1
Anti-Inflammatory Agents, Non-Steroidal
1
mehr ...